Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
200 participants
INTERVENTIONAL
2018-10-31
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Efficacy of Baclofen for Treatment of Muscle Spasms in Patients With Cirrhosis: A Pilot Study
NCT02298868
Botulinum Toxin for Cramps in Diabetic Neuropathy
NCT03238898
Botox Injections in Non-Cranial Nerve VII Innervated Muscles for Facial Synkinesis
NCT07295288
Botulinum Toxin A in Patients With Myofascial Pain Syndrome With and Without Zinc Supplementation
NCT05605886
A Comparative Study on the Impact of Trigger Points Injection of Platelet Rich Plasma Versus Botulinum Toxin on the Relief of Jaw Muscles Myofascial Pain
NCT06814535
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
\- Cyclobenzaprine, is a muscle relaxer medication used to relieve skeletal muscle spasms. It is one of the best-studied drug for this application.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cyclobenzaprine
Cyclobenzaprine administration for 2 weeks
Cyclobenzaprine
cyclobenzaprine administration for 2 weeks
PLacebo
Calcium carbonate for 2 weeks
Calcium Carbonate
Calcium carbonate for 2 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cyclobenzaprine
cyclobenzaprine administration for 2 weeks
Calcium Carbonate
Calcium carbonate for 2 weeks
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Encephalopathy.
* Receiving antidepressant drugs
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tanta University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sherief Abd-Elsalam
Consultant liver and GIT diseases- Tanta university hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sherief M. Abd-Elsalam, Consultant
Role: PRINCIPAL_INVESTIGATOR
liver diseases dept.- Tanta university hospital
Walaa A. Elkhalawany, Consultant
Role: STUDY_DIRECTOR
liver diseases dept.- Tanta university hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tanta university - faculty of medicine
Tanta, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Muscle cramps treatment
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.